US Stock MarketDetailed Quotes
INRX Intrinsic Medicine
- 0.000
- 0.0000.00%
Trading May 3 09:30 ET
0Market Cap0.00P/E (TTM)
0.000High0.000Low0Volume0.000Open0.000Pre Close0.00Turnover0.00%Turnover Ratio0.00P/E (Static)11.29MShares0.00052wk High0.00P/B0Float Cap0.00052wk Low--Dividend TTM4.17MShs Float0.000Historical High--Div YieldTTM0.00%Amplitude0.000Historical Low--Avg Price1Lot Size
Intrinsic Medicine Key Stats
Quarterly+Annual
YOY
| (FY)Dec 31, 2021 | (FY)Dec 31, 2020 | |
|---|---|---|
| Operating Cash Flow (Indirect Method) | ||
| Cash flow from continuing operating activities | -248.05%-3.04M | -874K |
| Net income from continuing operations | -499.45%-11.95M | ---1.99M |
| Operating gains losses | 1,287.28%6.98M | --503K |
| Other non cash items | 129.64%1.41M | --614K |
| Change In working capital | 1,695.00%319K | ---20K |
| -Change in prepaid assets | -186.67%-86K | ---30K |
| -Change in payables and accrued expense | 3,950.00%405K | --10K |
| Cash from discontinued investing activities | ||
| Operating cash flow | -248.05%-3.04M | ---874K |
| Investing cash flow | ||
| Cash flow from continuing investing activities | ||
| Cash from discontinued investing activities | ||
| Financing cash flow | ||
| Cash flow from continuing financing activities | 217.41%5M | 1.57M |
| Net issuance payments of debt | 359.12%4.93M | --1.07M |
| Proceeds from stock option exercised by employees | -25.40%373K | --500K |
| Net other financing activities | ---308K | ---- |
| Cash from discontinued financing activities | ||
| Financing cash flow | 217.41%5M | --1.57M |
| Net cash flow | ||
| Beginning cash position | 583.33%820K | --120K |
| Current changes in cash | 179.14%1.95M | --700K |
| End cash Position | 238.29%2.77M | --820K |
| Free cash flow | -248.05%-3.04M | ---874K |
| Currency Unit | USD | USD |
| Audit Opinions | Unqualified Opinion with Explanatory Notes | -- |
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
%Chg